COMMUNIQUÉS West-GlobeNewswire

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
08/05/2018
REGULATED INFORMATION GHENT, Belgium, 8 May 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
Probiodrug AG to Publish its First Quarter 2018 Business Update on 15 May 2018
08/05/2018
Probiodrug AG to Publish its First Quarter 2018 Business Update on 15 May 2018 HALLE (SAALE), Germany, 8 May 2017 - Probiodrug AG (Euronext Amsterdam: PBD), a clinical stage biopharmaceutical company developing novel [...]
Immuron Reports Significant Alleviation of Colitis Symptoms in Preclinical Program
08/05/2018
Results confirm LPS Antagonist action of IMM-124E offers a novel therapeutic approach to induce or maintain remission in IBD MELBOURNE, Australia, May 07, 2018 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (NASDAQ: IMRN [...]
MediciNova Announces Plans to Collaborate with UCLA Researchers in Grant-Funded Clinical Trial of MN-166 (ibudilast) in Alcohol Use Disorder and Withdrawal
08/05/2018
LA JOLLA, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), [...]
Teligent, Inc. to Present at Deutsche Bank’s 43rd Annual Health Care Conference on Tuesday, May 8, 2018
08/05/2018
BUENA, N.J., May 07, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey based specialty generic pharmaceutical company, will be presenting at Deutsche Bank’s 43 rd Annual Health Care Conference. The [...]
Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) in Newly Diagnosed Multiple Myeloma
08/05/2018
Company Announcement DARZALEX (daratumumab) approved by U.S. FDA in combination with bortezomib, melphalan and prednisone for the treatment of patients with newly diagnosed multiple myeloma who are ineligible for [...]
MacroGenics to Present at Deutsche Bank Health Care Conference
08/05/2018
ROCKVILLE, MD, May 07, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Genesis Healthcare Expects to Release First Quarter 2018 Results on May 10, 2018
07/05/2018
KENNETT SQUARE, Pa., May 07, 2018 (GLOBE NEWSWIRE) -- Genesis HealthCare (NYSE: GEN ) (Genesis or the Company), one of the nation’s largest providers of post-acute care, today announced that it expects to release its [...]
Teligent, Inc. to Reschedule Conference Call for First Quarter 2018 Results
07/05/2018
BUENA, N.J., May 07, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey-based specialty generic pharmaceutical company, initially announced the Company would hold a conference call at 4:30pm ET on [...]
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/05/2018
SOUTH SAN FRANCISCO, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
Amedisys Reports First Quarter 2018 Financial Results and Reaffirms 2018 Guidance
07/05/2018
BATON ROUGE, La., May 07, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED ) today reported its financial results for the three month period ended March 31, 2018. Three Month Periods Ended March 31, 2018 and 2017 [...]
Loxo Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/05/2018
STAMFORD, Conn., May 07, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq: LOXO ), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, [...]
Forward Pharma Appeals the Decision of the Opposition Division to Revoke the EP2801355 Patent
07/05/2018
COPENHAGEN, Denmark, May 07, 2018 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq: FWP ) (“We” or “Forward” or the “Company”), today announced the filing of a notice of appeal of the decision of the Opposition Division [...]
Cytori to Webcast First Quarter Financial Results on May 10
07/05/2018
SAN DIEGO, May 07, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX ) will provide a live webcast of its first quarter financial results and business update on Thursday, May 10, 2018 at 5:30 PM Eastern [...]
Alliqua BioMedical, Inc. Announces Closing Asset Sale to Celularity Inc.
07/05/2018
Alliqua to return capital to shareholders Alliqua Retains H.C. Wainwright and Co. to evaluate strategic options LANGHORNE, Pa., May 07, 2018 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq: ALQA ) ("Alliqua" or " [...]
Aeterna Zentaris Reports First Quarter 2018 Financial and Operating Results
07/05/2018
CHARLESTON, S.C., May 07, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS ) (TSX: AEZS ) today reported financial and operating results for the first quarter ended March 31, 2018. All Amounts are in U.S. [...]
Agile Therapeutics Reports First Quarter 2018 Financial Results
07/05/2018
Current Business Plan Expected to Enable Cash to Fund Operations through the end of 2018 PRINCETON, N.J., May 07, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX ), a women's healthcare company, today [...]
Photocure ASA: Employee incentive program
07/05/2018
The board of directors of Photocure ASA resolved today a share capital increase as part of the employee long-term incentive program for restricted shares in the company. In addition, the board of directors resolved that [...]
Todd Wood joins Obalon Therapeutics, Inc. as Vice President Global Sales
07/05/2018
SAN DIEGO, May 07, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology company, announced today that Todd Wood has joined as Vice President Global Sales. Mr. [...]

Pages